Healthcare • Drug Manufacturers - Specialty & Generic
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if INCR is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
4 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
15 filers reported a long position in INCR for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $325.1K | 212.5K | Unchanged |
| CITADEL ADVISORS LLC | $118.7K | 107.9K | -19.4% |
| MOORE CAPITAL MANAGEMENT, LP | $107K | 97.3K | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC | $63.6K | 57.8K | -10.5% |
| Revisor Wealth Management LLC | $45.5K | 41.3K | +248% |
| Virtu Financial LLC | $25K | 22.5K | +18.7% |
| BlackRock, Inc. | $22.6K | 20.5K | -10.8% |
| GEODE CAPITAL MANAGEMENT, LLC | $22.4K | 20.4K | -9.7% |
| Atria Investments, Inc | $13.2K | 12K | New |
| Quent Capital, LLC | $11.4K | 10.3K | Unchanged |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.